Skip to Content
DAEWOONG PHARMACEUTICAL CO.LTD.
View All Menu
KR
EN
About Daewoong
About Daewoong
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Certification
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
Newsroom
Press Release
PR Videos
Investors
Overview
Corporate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events & Presentations
Earnings announcement
FAQ
Careers
Close All Menu
Overview
Stock info
Present value
134,000
Net change
drop
400(-0.30%)
Trading Value
22,063
IR Events
4Q24 Domestic NDR (BNK Securities)
1:1 Meeting & Conference Call
February 12~13, 2025
Earnings announcement
Business Update (1Q25)
File Download
Contact us :
dwir@daewoong.co.kr